AU2018351349B2 - Detection of symmetrical dimethylarginine - Google Patents

Detection of symmetrical dimethylarginine

Info

Publication number
AU2018351349B2
AU2018351349B2 AU2018351349A AU2018351349A AU2018351349B2 AU 2018351349 B2 AU2018351349 B2 AU 2018351349B2 AU 2018351349 A AU2018351349 A AU 2018351349A AU 2018351349 A AU2018351349 A AU 2018351349A AU 2018351349 B2 AU2018351349 B2 AU 2018351349B2
Authority
AU
Australia
Prior art keywords
sdma
mma
antibody
son
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018351349A
Other languages
English (en)
Other versions
AU2018351349A1 (en
Inventor
Sreenivasa Rao RAMISETTY
Hongzhi Xie
Murthy Vsn Yerramilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of AU2018351349A1 publication Critical patent/AU2018351349A1/en
Application granted granted Critical
Publication of AU2018351349B2 publication Critical patent/AU2018351349B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2018351349A 2017-10-19 2018-10-19 Detection of symmetrical dimethylarginine Active AU2018351349B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762574592P 2017-10-19 2017-10-19
US62/574,592 2017-10-19
US201762599117P 2017-12-15 2017-12-15
US62/599,117 2017-12-15
PCT/US2018/056687 WO2019079707A1 (en) 2017-10-19 2018-10-19 SYMMETRIC DIMETHYLARGININE DETECTION

Publications (2)

Publication Number Publication Date
AU2018351349A1 AU2018351349A1 (en) 2020-04-23
AU2018351349B2 true AU2018351349B2 (en) 2025-08-14

Family

ID=66170983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018351349A Active AU2018351349B2 (en) 2017-10-19 2018-10-19 Detection of symmetrical dimethylarginine

Country Status (11)

Country Link
US (2) US11422136B2 (enExample)
EP (1) EP3697499A4 (enExample)
JP (1) JP7398366B2 (enExample)
KR (1) KR20250034534A (enExample)
CN (1) CN111246918B (enExample)
AU (1) AU2018351349B2 (enExample)
CA (1) CA3079011A1 (enExample)
MX (1) MX2020003523A (enExample)
TW (1) TWI831753B (enExample)
WO (1) WO2019079707A1 (enExample)
ZA (1) ZA202002415B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010017089A1 (en) * 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for detecting symmetrical demethylarginine
KR102492243B1 (ko) * 2015-02-20 2023-01-25 아이덱스 래보러토리즈, 인코포레이티드 배경 신호에 대한 보상에 의한 균질 면역검정
CA3079011A1 (en) * 2017-10-19 2019-04-25 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
EP4025301A4 (en) 2019-09-05 2023-07-19 The Regents of the University of California NON-INVASIVE METHOD FOR QUANTIFYING KIDNEY FUNCTION AND FUNCTIONAL DECLINE
CN113125697B (zh) * 2019-12-31 2024-03-26 科美博阳诊断技术(上海)有限公司 一种睾酮均相化学发光检测试剂盒及其应用
CN115843342A (zh) 2020-04-17 2023-03-24 艾德克斯实验室公司 荧光淬灭免疫测定
WO2022133159A1 (en) 2020-12-17 2022-06-23 Nephrosant, Inc. Kits for stabilization of urine samples
WO2025070448A1 (ja) * 2023-09-26 2025-04-03 富士フイルム株式会社 対称性ジメチルアルギニンを測定するためのキットおよび対称性ジメチルアルギニンの測定方法
WO2025205769A1 (ja) * 2024-03-26 2025-10-02 富士フイルム株式会社 α－アミラーゼと対称性ジメチルアルギニンとのコンジュゲート、およびその応用

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686181A (en) * 1984-03-09 1987-08-11 Miles Laboratories, Inc. Specific binding assay employing anti-G6PDH as label
US20060040408A1 (en) * 2004-03-30 2006-02-23 Whatman, Inc. Lateral flow format, materials and methods
WO2006078813A2 (en) * 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
US7611844B2 (en) * 2002-11-15 2009-11-03 Board Of Trustees Of The Leland Stanford Jr. University Methods for detecting asymmetric dimethylarginine in a biological sample
US20100035274A1 (en) * 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for Detecting Symmetrical Dimethylarginine
CN102628868A (zh) * 2011-12-30 2012-08-08 北京九强生物技术股份有限公司 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒
US20120214978A1 (en) * 2011-02-17 2012-08-23 Siemens Healthcare Diagnostics Inc. Reducing Non-Covalently Bound Polysaccharide On Supports
US20140315216A1 (en) * 2012-01-10 2014-10-23 Idexx Laboratories, Inc. Immunoassay Test Slide
US20160187348A1 (en) * 2013-09-05 2016-06-30 Idexx Laboratories, Inc. Methods for Detecting Renal Disease
US20160187324A1 (en) * 2005-04-28 2016-06-30 Ventana Medical Systems, Inc. Antibody Conjugates
WO2016134251A1 (en) * 2015-02-20 2016-08-25 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
DE3134787A1 (de) 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5710009A (en) * 1994-02-17 1998-01-20 Serex, Inc. Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
AU7269098A (en) 1997-05-01 1998-11-24 Cooke Pharma, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
AU2452301A (en) 1999-12-22 2001-07-03 Research Foundation Of The State University Of New York, The Protein methylarginine-specific antibodies
JP2004502948A (ja) * 2000-07-06 2004-01-29 ファル　ダイアグノスティクス アルギニン化合物の検出のための方法及びキット
AU2001293699A1 (en) 2000-07-12 2002-01-21 Werner Naser Direct assessment of analyte to reference molecule ratios
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
FR2824825B1 (fr) 2001-05-15 2005-05-06 Servier Lab Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
JP2004279412A (ja) * 2003-02-24 2004-10-07 Sanwa Kagaku Kenkyusho Co Ltd 低分子化合物の免疫学的測定・検出方法
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE602004020360D1 (de) 2004-11-04 2009-05-14 Germediq Forsch & Entw Ges Mbh Methode zur Bestimmung von Arginin, methylierten Argininen und deren Derivate
CN1786713A (zh) * 2004-12-09 2006-06-14 陈金华 酶标仪在胶乳增强免疫透射比浊法中的应用
DE102005060057A1 (de) 2005-12-15 2007-06-28 Kellner, Karl-Heinz, Dr. Sandwich-Immunoassay für kleine Haptenmoleküle
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
CA2708033C (en) 2007-12-05 2019-07-02 King's College London Methods and compositions
JP2012529015A (ja) 2009-06-02 2012-11-15 バイオクラテス ライフ サイエンシーズ アーゲー 腎臓疾患評価用新規バイオマーカー
CN101587118B (zh) 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
JP5974892B2 (ja) * 2010-08-31 2016-08-23 コニカミノルタ株式会社 生体物質検出方法
DE102011055265A1 (de) 2010-11-17 2012-05-24 Karl-Heinz Kellner Automatenfähiger Immunoassay für biogene Amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
US20140038203A1 (en) 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
US9304126B2 (en) 2012-08-21 2016-04-05 Janssen Pharmaceutica Nv Haptens of quetiapine
CA3079011A1 (en) 2017-10-19 2019-04-25 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
CN108469419A (zh) * 2018-03-09 2018-08-31 山东泰邦生物制品有限公司 采用酶标仪免疫透射比浊法高通量检测IgG含量的方法

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686181A (en) * 1984-03-09 1987-08-11 Miles Laboratories, Inc. Specific binding assay employing anti-G6PDH as label
US7611844B2 (en) * 2002-11-15 2009-11-03 Board Of Trustees Of The Leland Stanford Jr. University Methods for detecting asymmetric dimethylarginine in a biological sample
US20060040408A1 (en) * 2004-03-30 2006-02-23 Whatman, Inc. Lateral flow format, materials and methods
WO2006078813A2 (en) * 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
US20160187324A1 (en) * 2005-04-28 2016-06-30 Ventana Medical Systems, Inc. Antibody Conjugates
US20100035274A1 (en) * 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for Detecting Symmetrical Dimethylarginine
US20120214978A1 (en) * 2011-02-17 2012-08-23 Siemens Healthcare Diagnostics Inc. Reducing Non-Covalently Bound Polysaccharide On Supports
CN102628868A (zh) * 2011-12-30 2012-08-08 北京九强生物技术股份有限公司 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒
US20140315216A1 (en) * 2012-01-10 2014-10-23 Idexx Laboratories, Inc. Immunoassay Test Slide
US20160187348A1 (en) * 2013-09-05 2016-06-30 Idexx Laboratories, Inc. Methods for Detecting Renal Disease
WO2016134251A1 (en) * 2015-02-20 2016-08-25 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DLD Diagnostika GmbH., 'Instructions for use SDMA-ELISA: Enzyme Immunoassay for the Quantitative Determination of Endogenous Symmetric Dimethylarginine (SDMA) in Serum or Plasma', (2011-08-01), pages 1-16, *
Honda, S. et al., 'Analysis of sDMA modifications of PIWI proteins', Methods in Molecular Biology, (2013-10-07), vol. 1093, pages 137 - 148, doi:10.1007/978-1-62703-694-8_11. *
Kaptein, E. 'Thyroid Hormone Metabolism and Thyroid Diseases in Chronic Renal Failure', Endocrine Review, (1996-02-01), vol. 17, no. 1, pages 45 - 63. *

Also Published As

Publication number Publication date
BR112020007150A2 (pt) 2020-09-24
US20190120856A1 (en) 2019-04-25
TWI831753B (zh) 2024-02-11
ZA202002415B (en) 2023-09-27
US11422136B2 (en) 2022-08-23
EP3697499A1 (en) 2020-08-26
JP2021500551A (ja) 2021-01-07
KR20200073259A (ko) 2020-06-23
CN111246918B (zh) 2024-06-14
MX2020003523A (es) 2020-07-22
EP3697499A4 (en) 2021-07-21
US20230102277A1 (en) 2023-03-30
TW201923349A (zh) 2019-06-16
CA3079011A1 (en) 2019-04-25
CN111246918A (zh) 2020-06-05
KR20250034534A (ko) 2025-03-11
JP7398366B2 (ja) 2023-12-14
AU2018351349A1 (en) 2020-04-23
WO2019079707A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
AU2018351349B2 (en) Detection of symmetrical dimethylarginine
US20220221446A1 (en) Methods for Detecting Symmetrical Dimethylarginine
JP2023056523A (ja) 対称性ジメチル化アルギニン分析物に対する抗体及びその用途
JP2021181994A (ja) 腎疾患の検出方法
JP4668768B2 (ja) 免疫測定方法及び非特異反応抑制方法
KR101974230B1 (ko) Pivka-ii 측정 시약에서의 비특이 반응의 억제 방법
KR102902843B1 (ko) 대칭 디메틸아르기닌의 검출
US9127039B2 (en) Sulfur-containing amino acid derivative
BR112020007150B1 (pt) Métodos e kit para determinação de dimetilarginina simétrica (sdma) em uma amostra, dispositivo, reagente de captura, fase sólida e composição de um derivado de arginina
JP2003344397A (ja) 免疫学的測定方法、それに用いる試験片、および免疫学的測定装置
TWI902784B (zh) 螢光淬滅免疫分析
Cernoch et al. Production and analytical characterization of neopterin immunoreagents for biosensor developments
JP2003083966A (ja) 抗原／抗体水溶液

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)